Log in  First Connection?

Virus: Archives News of the month

Seroprevalence of SARS-CoV-2 antibodies in patients with hematological and oncological diseases in early 2024
Virus
 3 min.

 Published on 03/04/2025 |  Original article (Abstract)  | Cremer Louise M. et al. | Blood research 2025; 60(1): 19

The Coronavirus Disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses unique challenges to healthcare systems worldwide. Among vulnerable populations, individuals with hematological and oncological diseases have drawn particular attention because...

Integration of the national HIV curriculum in medicine, nursing, and pharmacy programs in the United States
Virus
 6 min.

 Published on 27/03/2025 |  Original article (Abstract)  | Wagner Cornelia et al. | BMC Medical Education 2025; 25(1): 422

As a result of advancements in the treatment of HIV, more people with HIV/AIDS in the United States worldwide will live near-normal life spans, increasing the demand for HIV care and care for comorbidities associated with aging. Concomitantly, the first generation of HIV clinicians are retiring from...

SARS-CoV-2 genomic evolution during a severe and long-lasting omicron infection under antiviral therapy
Virus
 4 min.

 Published on 20/03/2025 |  Original article (Abstract)  | Bolis Matteo et al. | BMC Infectious Diseases 2025; 25(1): 359

As widely described since the first phases of the pandemic, immunocompromised individuals are at higher risk of developing prolonged SARS-CoV-2 infection with respect to the general population [1, 2, 3, 4, 5–6]. This fragile population cannot efficiently respond to vaccination and is impaired in...

Effect of SARS-CoV-2 infection on human embryonic development and clinical outcomes: a retrospective cohort study
Virus
 4 min.

 Published on 13/03/2025 |  Original article (Abstract)  | Tian Li et al. | BMC Pregnancy and Childbirth 2025; 25(1): 251

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes coronavirus disease 2019 (COVID-19). The SARS-CoV-2 virus enters target host cells through the angiotensin-converting enzyme 2 (ACE2) or cellular transmembrane serine protease 2 (TMPRSS2) route [1, 2–3]. These route are...

Telemedicine virologic and immunologic outcomes in people living with HIV (PLWH) in a correctional setting during the SARS-CoV-2 pandemic
Virus
 3 min.

 Published on 06/03/2025 |  Original article (Abstract)  | Patel Dimple et al. | BMC Infectious Diseases 2025; 25(1): 289

Telemedicine is used in a multitude of settings to fill in various gaps in healthcare. These include the opportunity to overcome geographic limitations of health care delivery for patients who do not have adequate transportation. The theory behind telemedicine is that it may increase adherence to medications...